Stock BINV BIOINVENT INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up

Revisions BioInvent International AB

Equities

BINV

SE0015244520

Market Closed - Nasdaq Stockholm
Other stock markets
 11:29:36 2024-04-26 am EDT 		5-day change 1st Jan Change
25.15 SEK +1.62% Intraday chart for BioInvent International AB +6.12% +32.65%
Apr. 24 BioInvent International AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 03 BioInvent, Merck & Co. Unit Sign Clinical Trial, Supply Deal for Tumor Treatment as Add-On Therapy for Keytruda MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. BINV Stock
  4. Revisions BioInvent International AB